Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study

Abstract

Elevated serum IGF-1 levels may be an important predictor of risk for prostate cancer. However, our results do not support an important role for serum IGFBP-3 as a predictor of risk for this disease.